GSK’s new vaccine hire looks beyond COVID in quest for next hit: ‘The potential is there to really make a much better flu vaccine’

GSK Plc is planning to launch a COVID shot that comes almost two years after Pfizer Inc. took the world by storm. For Phil Dormitzer, it’s a reminder of why he was hired at the UK drugmaker: to help return its immunization business to the top after it stumbled during the pandemic. Read More